ANA Therapeutics

ANA Therapeutics

Verified
Founded in response to the COVID-19 pandemic, we’re investigating niclosamide as a treatment for COVID-19.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$20—30m (Dealroom.co estimates Aug 2020.)
San Mateo California (HQ)

Authorizing premium user...